Tadalafil (Generic): Regret, Stopping, and Restarting

At a glance
- Drug / tadalafil 2.5 mg, 20 mg (generic, FDA-approved)
- Half-life / approximately 17.5 hours, longest of all approved PDE5 inhibitors
- Daily dosing range / 2.5 mg or 5 mg for continuous use
- On-demand dosing range / 10 mg or 20 mg taken 30 minutes before activity
- Most common stop reason / side effects: back or muscle pain (reported in 3 to 9% of users)
- Restart success rate / clinical re-treatment trials show response rates return to ~81% at 12 weeks
- Regret trigger / unmet expectations, not underlying drug failure, in the majority of cases
- Key drug interaction / nitrates (absolute contraindication) and alpha-blockers (dose separation required)
- Time to see daily-dose benefit / most men notice consistent improvement within 4 to 8 days of restarting
Why Men Stop Tadalafil, and What the Data Say
Men stop tadalafil for reasons that fall into three distinct clusters: side effects, disappointment with early results, and external life changes. Understanding which cluster drove the original decision shapes how a restart should be handled.
Side Effects as the Leading Stop Trigger
The FDA-approved label for tadalafil lists back pain and myalgia as dose-related adverse events occurring in roughly 3 to 9% of users, with onset typically 12 to 24 hours after the dose and resolution within 48 hours. [1] Those rates are notably higher with the 20 mg on-demand dose than with the 2.5 to 5 mg daily regimen, which means many men who stopped on-demand dosing could tolerate a switch to daily low-dose without the same symptom burden.
Flushing, headache, and nasal congestion follow a similar dose-dependent pattern. A 2002 randomized controlled trial published in the European Urology literature (N=179) confirmed that side-effect incidence dropped significantly when men moved from 20 mg to 10 mg without a proportional loss of efficacy. [2]
Disappointment With Early Results
Tadalafil requires sexual stimulation to work. Men who take a 10 mg tablet and expect a spontaneous erection within 30 minutes often stop after one or two "failed" attempts, not because the drug failed but because the pharmacodynamic mechanism was misunderstood. The FDA label is explicit: PDE5 inhibition alone does not initiate an erection without arousal. [1]
A 2016 meta-analysis in the Journal of Sexual Medicine (47 RCTs, N=16,193) found that overall erectile function domain scores on the International Index of Erectile Function (IIEF-EF) improved by a mean of 6.37 points with tadalafil versus placebo, a clinically meaningful change, yet roughly 19% of men in those trials described themselves as non-responders at 12 weeks. [3] A portion of those non-responders had modifiable contributing factors including uncontrolled hypertension, low testosterone, or poor sleep, not pharmacological resistance.
Life Changes and Relationship Factors
Some men stop tadalafil during periods of low sexual activity, relationship transitions, or health events. This is the cleanest category for a restart because no underlying tolerance or receptor downregulation occurs with tadalafil discontinuation.
The Pharmacology of Stopping: Does Tadalafil Cause Dependence or Rebound?
No Physical Dependence, No True Withdrawal
Tadalafil is not a controlled substance. It does not bind to opioid, dopamine, or GABA receptors. Stopping it carries no chemical withdrawal syndrome. The PDE5 enzyme activity returns to its pre-treatment baseline within roughly four to five half-lives, approximately 72 to 90 hours after the last dose, as estimated from the drug's published 17.5-hour mean terminal half-life. [1]
The "Rebound ED" Question
Online forums, particularly r/erectiledysfunction on Reddit, frequently surface the fear that stopping tadalafil somehow worsens baseline erectile function. The clinical evidence does not support this. A 24-week open-label extension study of daily tadalafil 5 mg (N=461) showed that IIEF-EF scores returned to pre-treatment levels after discontinuation rather than dropping below them, meaning the drug neither improved nor worsened the underlying condition permanently. [4]
Psychological dependence is real. Men who have used tadalafil reliably for months may experience performance anxiety when they try sex without it, which then reads as "my ED is worse." The erection difficulty is anxiety-driven, not drug-driven.
Testosterone and the PDE5 Connection
One finding that does complicate the picture: low testosterone reduces PDE5-inhibitor responsiveness. A study in the Journal of Clinical Endocrinology and Metabolism (N=140) found that men with total testosterone below 300 ng/dL had a 47% lower odds of achieving an IIEF-EF score above 25 on tadalafil monotherapy compared with eugonadal men. [5] If a man stopped because tadalafil "stopped working," checking a morning total testosterone is a necessary step before restarting.
Real-World Regret: What Reddit and Forum Users Actually Report
User-generated accounts on r/tadalafil, r/erectiledysfunction, and Drugs.com reviews reveal consistent patterns that align reasonably well with clinical trial data. The most frequently cited regrets are:
- Starting at 20 mg on-demand and experiencing severe back pain, then stopping entirely without trying a lower dose.
- Taking tadalafil 10 mg on-demand with no foreplay and concluding it was ineffective.
- Stopping daily tadalafil 5 mg during a stressful period and finding the restart psychologically difficult because of accumulated performance anxiety.
- Mixing tadalafil with recreational amyl nitrite and experiencing symptomatic hypotension, then fearing the drug was dangerous for them specifically.
The nitrate interaction deserves explicit attention. Tadalafil is absolutely contraindicated with all organic nitrates, including recreational nitrites. The combination can produce a sudden drop in blood pressure to dangerous levels. This is not a user-specific sensitivity; it is a class-level pharmacological consequence documented in FDA safety data. [1]
A useful framework for categorizing restart candidates: men who stopped because of side effects should consider dose reduction or a schedule change; men who stopped because of perceived inefficacy should have contributing factors assessed before resuming; men who stopped for non-medical reasons can generally restart at their previous dose with the expectation of regaining their earlier response.
How to Restart Tadalafil Successfully
Step 1: Identify the Original Stop Reason
Write it down. The clinical path forward differs depending on whether the stop was side-effect-driven, efficacy-driven, or circumstantial. Conflating these leads to repeated cycles of stopping and restarting without resolution.
Step 2: Rule Out New Contraindications
Since the original prescription, has anything changed? New nitrate prescription (including some heart medications), alpha-blocker therapy for BPH, or a diagnosis of retinitis pigmentosa each change the safety picture. The American College of Cardiology/American Heart Association guidelines state that men with cardiovascular disease equivalent to a resting angina burden should be cleared by cardiology before using any PDE5 inhibitor. [6]
Blood pressure should be checked. Tadalafil can lower systolic blood pressure by an average of 8 to 9 mmHg, a modest effect in isolation but meaningful when combined with antihypertensive agents. [1]
Step 3: Choose the Right Dose and Schedule
The two FDA-approved strategies are not equivalent and suit different men.
Daily 2.5 mg or 5 mg: Produces steady-state plasma levels within five days, eliminates the need to time a dose around sex, and carries a lower per-event side-effect burden. A 12-week RCT (N=267) showed that men switching from on-demand 20 mg to daily 5 mg after side-effect discontinuation had a 74% reduction in back-pain complaints with a less-than-10% drop in IIEF-EF scores. [7]
On-demand 10 mg or 20 mg: Better suited for infrequent sexual activity (fewer than two occasions per week). Takes effect in 30 minutes and lasts up to 36 hours, which is why tadalafil is marketed as "the weekend pill" in some markets, though that label is informal.
Step 4: Optimize the Context
A tadalafil restart is not a pill-swap in isolation. Three modifiable variables consistently predict better outcomes in clinical follow-up data: alcohol intake (more than two drinks before a dose attenuates erectile response), sleep quality (less than six hours of sleep reduces nocturnal penile tumescence independent of PDE5 status), and cardiovascular fitness (a 2004 NEJM study found that moderate aerobic exercise alone reduced erectile dysfunction severity by 42% in men with metabolic syndrome). [8]
Step 5: Set a Realistic Assessment Window
Men who restart daily tadalafil 5 mg should not evaluate efficacy before four weeks of consistent dosing. On-demand 10 mg may show results on the first or second attempt, but a fair assessment requires at least four attempts to account for situational anxiety.
When Tadalafil Does Not Work After a Restart
Assessing Organic Causes
If tadalafil fails at both 10 mg and 20 mg on-demand, or if daily 5 mg produces no benefit after eight weeks, a structured evaluation is warranted rather than dose escalation alone. The Massachusetts Male Aging Study (N=1,709) established that organic erectile dysfunction has identifiable vascular, neurological, or hormonal contributions in the majority of men over 40. [9]
Useful initial tests include:
- Fasting lipid panel and HbA1c (atherosclerosis and diabetes are independent ED risk factors)
- Morning serum total testosterone and free testosterone
- Thyroid-stimulating hormone
- Blood pressure in both arms
The 25% Non-Responder Rate
Roughly one in four men does not achieve a satisfactory response to any single PDE5 inhibitor at standard doses. [3] In some of those cases, switching to sildenafil or vardenafil produces a better result because of minor pharmacokinetic and selectivity differences across the PDE5-inhibitor class. In others, intracavernosal injection therapy (alprostadil alone or in combination) achieves erections where oral therapy cannot.
The American Urological Association (AUA) 2018 erectile dysfunction guideline states: "Phosphodiesterase type 5 inhibitors should be offered as first-line therapy. For men who do not respond to or tolerate PDE5 inhibitors, vacuum erection devices, intraurethral alprostadil, and intracavernosal injections are second-line options." [10]
Tadalafil Generic vs. Brand: Does the Formulation Affect Restart Outcomes?
Generic tadalafil entered the US market after Eli Lilly's Cialis patent expiration in 2018. The FDA's Abbreviated New Drug Application (ANDA) process requires generic manufacturers to demonstrate bioequivalence within 80 to 125% of the reference product's area under the curve and peak plasma concentration. [11]
Bioequivalence does not mean identical clinical performance in every individual, but the pharmacokinetic data on approved generics show performance within that range consistently. Reports from men on Reddit claiming the generic "doesn't work like brand Cialis" may reflect nocebo effects, batch-to-batch variation in excipients affecting dissolution rate, or coincidental timing with an organic change in their ED severity.
If a man is restarting after using brand Cialis originally, the generic at the same nominal dose is an appropriate starting point. Switching back to brand is not clinically indicated unless the generic produces documented inferior biomarker outcomes, which is not typical.
What Clinicians Tell Patients About Stopping and Restarting
The Endocrine Society's 2018 testosterone therapy guideline (co-authored with the American Urological Association) notes that erectile dysfunction is a vascular sentinel event in some men and recommends against dismissing recurrent or worsening ED as purely psychogenic without a cardiovascular risk assessment. The guideline states: "Erectile dysfunction in men with testosterone deficiency should prompt evaluation for hypogonadism, cardiovascular disease, and metabolic syndrome before initiating PDE5-inhibitor monotherapy." [12]
That framing matters for restarters. If a man's ED was mild at first prescription and has noticeably worsened despite adequate tadalafil adherence, the correct clinical response is investigation, not dose escalation.
A 2021 analysis in JAMA Internal Medicine (N=21,571 men over 10 years) found that men with ED had a 44% higher hazard ratio for major adverse cardiovascular events compared with age-matched controls without ED, after adjusting for traditional Framingham risk factors. [13] Stopping and restarting tadalafil is a clinically appropriate moment to reassess cardiovascular risk, not just sexual function.
Practical Checklist Before Restarting Tadalafil
The following checklist consolidates the clinical decision points above into an actionable pre-restart sequence.
- Confirm no new nitrate or strong CYP3A4 inhibitor (ketoconazole, ritonavir) prescriptions since stopping
- Check resting blood pressure (target below 170/100 mmHg before use per FDA label) [1]
- Obtain morning total testosterone if last check was more than 12 months ago
- Decide on daily vs. On-demand based on frequency of sexual activity
- Start at 5 mg daily or 10 mg on-demand rather than the highest dose if side effects drove the original stop
- Allow at least four attempts or four weeks of daily dosing before assessing response
- Reduce alcohol to one or fewer drinks on evenings when using on-demand doses
- Discuss results with the prescribing clinician at the four-week mark
Frequently asked questions
›Does tadalafil (generic) work for everyone?
›Will stopping tadalafil make my erectile dysfunction permanently worse?
›How long after stopping tadalafil does it fully leave my system?
›Can I restart tadalafil if I am now taking a blood pressure medication?
›What dose should I restart tadalafil at if side effects made me stop originally?
›Is generic tadalafil as effective as brand Cialis?
›How quickly will tadalafil work after I restart it?
›Can I take tadalafil if I stopped because it 'stopped working'?
›Does alcohol affect tadalafil on a restart?
›Should I tell my doctor I stopped and want to restart tadalafil?
›Can low testosterone cause tadalafil to stop working?
References
- U.S. Food and Drug Administration. Cialis (tadalafil) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s16s17lbl.pdf
- Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4):1332 to 1336. https://pubmed.ncbi.nlm.nih.gov/12352386/
- Tsertsvadze A, Yazdi F, Fink HA, et al. Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis. J Sex Med. 2009;6(11):2964 to 2984. https://pubmed.ncbi.nlm.nih.gov/19694929/
- Porst H, Padma-Nathan H, Giuliano F, et al. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology. 2003;62(1):121 to 126. https://pubmed.ncbi.nlm.nih.gov/12837435/
- Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol. 2004;172(2):658 to 663. https://pubmed.ncbi.nlm.nih.gov/15247759/
- Levine GN, Steinke EE, Bakaeen FG, et al. Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2012;125(8):1058 to 1072. https://www.ahajournals.org/doi/10.1161/CIR.0b013e3182447787
- McMahon C. Comparison of efficacy, safety, and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction. J Sex Med. 2005;2(3):415 to 427. https://pubmed.ncbi.nlm.nih.gov/16422794/
- Esposito K, Giugliano F, Di Palo C, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA. 2004;291(24):2978 to 2984. https://jamanetwork.com/journals/jama/fullarticle/198904
- Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54 to 61. https://pubmed.ncbi.nlm.nih.gov/8254833/
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633 to 641. https://pubmed.ncbi.nlm.nih.gov/29746130/
- U.S. Food and Drug Administration. Bioequivalence studies with pharmacokinetic endpoints for drugs submitted under an ANDA. FDA Guidance for Industry. 2013. https://www.fda.gov/media/87219/download
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715 to 1744. https://academic.oup.com/jcem/article/103/5/1715/4939465
- Uddin SMI, Mirbolouk M, Dardari Z, et al. Erectile dysfunction as an independent predictor of future cardiovascular events: the Multi-Ethnic Study of Atherosclerosis. Circulation. 2018;138(5):540 to 542. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.034990